262 related articles for article (PubMed ID: 12452431)
21. Electronic ground states of iron porphyrin and of the first species in the catalytic reaction cycle of cytochrome P450s.
Groenhof AR; Swart M; Ehlers AW; Lammertsma K
J Phys Chem A; 2005 Apr; 109(15):3411-7. PubMed ID: 16833677
[TBL] [Abstract][Full Text] [Related]
22. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
23. Kinetic isotope effects implicate two electrophilic oxidants in cytochrome p450-catalyzed hydroxylations.
Newcomb M; Aebisher D; Shen R; Chandrasena RE; Hollenberg PF; Coon MJ
J Am Chem Soc; 2003 May; 125(20):6064-5. PubMed ID: 12785830
[TBL] [Abstract][Full Text] [Related]
24. Separation of electron-transfer and coupled chemical reaction components of biocatalytic processes using Fourier transform ac voltammetry.
Fleming BD; Zhang J; Bond AM; Bell SG; Wong LL
Anal Chem; 2005 Jun; 77(11):3502-10. PubMed ID: 15924381
[TBL] [Abstract][Full Text] [Related]
25. The influence of substrate on the spectral properties of oxyferrous wild-type and T252A cytochrome P450-CAM.
Sono M; Perera R; Jin S; Makris TM; Sligar SG; Bryson TA; Dawson JH
Arch Biochem Biophys; 2005 Apr; 436(1):40-9. PubMed ID: 15752707
[TBL] [Abstract][Full Text] [Related]
26. Comparison between electrochemistry/mass spectrometry and cytochrome P450 catalyzed oxidation reactions.
Jurva U; Wikström HV; Weidolf L; Bruins AP
Rapid Commun Mass Spectrom; 2003; 17(8):800-10. PubMed ID: 12672134
[TBL] [Abstract][Full Text] [Related]
27. Kinetic analysis of lauric acid hydroxylation by human cytochrome P450 4A11.
Kim D; Cha GS; Nagy LD; Yun CH; Guengerich FP
Biochemistry; 2014 Oct; 53(39):6161-72. PubMed ID: 25203493
[TBL] [Abstract][Full Text] [Related]
28. Modulation of redox potential and alteration in reactivity via the peroxide shunt pathway by mutation of cytochrome P450 around the proximal heme ligand.
Matsumura H; Wakatabi M; Omi S; Ohtaki A; Nakamura N; Yohda M; Ohno H
Biochemistry; 2008 Apr; 47(16):4834-42. PubMed ID: 18363338
[TBL] [Abstract][Full Text] [Related]
29. Kinetic isotope effects implicate a single oxidant for cytochrome P450-mediated O-dealkylation, N-oxygenation, and aromatic hydroxylation of 6-methoxyquinoline.
Dowers TS; Jones JP
Drug Metab Dispos; 2006 Aug; 34(8):1288-90. PubMed ID: 16714370
[TBL] [Abstract][Full Text] [Related]
30. Formation of the active species of cytochrome p450 by using iodosylbenzene: a case for spin-selective reactivity.
Cho KB; Moreau Y; Kumar D; Rock DA; Jones JP; Shaik S
Chemistry; 2007; 13(14):4103-15. PubMed ID: 17367100
[TBL] [Abstract][Full Text] [Related]
31. Computational evidence for α-nitrosamino radical as initial metabolite for both the P450 dealkylation and denitrosation of carcinogenic nitrosamines.
Ji L; Schüürmann G
J Phys Chem B; 2012 Jan; 116(2):903-12. PubMed ID: 22136655
[TBL] [Abstract][Full Text] [Related]
32. Oxidation of methoxyphenethylamines by cytochrome P450 2D6. Analysis of rate-limiting steps.
Guengerich FP; Miller GP; Hanna IH; Sato H; Martin MV
J Biol Chem; 2002 Sep; 277(37):33711-9. PubMed ID: 12093814
[TBL] [Abstract][Full Text] [Related]
33. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
34. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants.
Yun CH; Miller GP; Guengerich FP
Biochemistry; 2000 Sep; 39(37):11319-29. PubMed ID: 10985777
[TBL] [Abstract][Full Text] [Related]
35. Density functional studies on isomerization of prostaglandin H2 to prostacyclin catalyzed by cytochrome P450.
Yanai TK; Mori S
Chemistry; 2009; 15(17):4464-73. PubMed ID: 19283807
[TBL] [Abstract][Full Text] [Related]
36. Identification of cytochrome P450 enzymes involved in the metabolism of the designer drugs N-(1-phenylcyclohexyl)-3-ethoxypropanamine and N-(1-phenylcyclohexyl)-3-methoxypropanamine.
Sauer C; Peters FT; Schwaninger AE; Meyer MR; Maurer HH
Chem Res Toxicol; 2008 Oct; 21(10):1949-55. PubMed ID: 18778087
[TBL] [Abstract][Full Text] [Related]
37. Theoretical and experimental studies of the conversion of chromopyrrolic acid to an antitumor derivative by cytochrome P450 StaP: the catalytic role of water molecules.
Wang Y; Chen H; Makino M; Shiro Y; Nagano S; Asamizu S; Onaka H; Shaik S
J Am Chem Soc; 2009 May; 131(19):6748-62. PubMed ID: 19385626
[TBL] [Abstract][Full Text] [Related]
38. Electrochemical reduction of flavocytochromes 2B4 and 1A2 and their catalytic activity.
Shumyantseva VV; Bulko TV; Bachmann TT; Bilitewski U; Schmid RD; Archakov AI
Arch Biochem Biophys; 2000 May; 377(1):43-8. PubMed ID: 10775439
[TBL] [Abstract][Full Text] [Related]
39. [Metalloporphyrin catalyzed biomimetic oxidation potentials: potential uses and applications].
Balogh GT; Keserü GM
Acta Pharm Hung; 2003; 73(3):153-62. PubMed ID: 15112438
[TBL] [Abstract][Full Text] [Related]
40. Model electrochemical-mass spectrometric studies of the cytochrome P450-catalyzed oxidations of cyclic tertiary allylamines.
Jurva U; Bissel P; Isin EM; Igarashi K; Kuttab S; Castagnoli N
J Am Chem Soc; 2005 Sep; 127(35):12368-77. PubMed ID: 16131218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
